BC11B_HUMAN - dbPTM
BC11B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID BC11B_HUMAN
UniProt AC Q9C0K0
Protein Name B-cell lymphoma/leukemia 11B
Gene Name BCL11B
Organism Homo sapiens (Human).
Sequence Length 894
Subcellular Localization Nucleus .
Protein Description Key regulator of both differentiation and survival of T-lymphocytes during thymocyte development in mammals. Essential in controlling the responsiveness of hematopoietic stem cells to chemotactic signals by modulating the expression of the receptors CCR7 and CCR9, which direct the movement of progenitor cells from the bone marrow to the thymus. [PubMed: 27959755 Is a regulator of IL2 promoter and enhances IL2 expression in activated CD4(+) T-lymphocytes]
Protein Sequence MSRRKQGNPQHLSQRELITPEADHVEAAILEEDEGLEIEEPSGLGLMVGGPDPDLLTCGQCQMNFPLGDILVFIEHKRKQCGGSLGACYDKALDKDSPPPSSRSELRKVSEPVEIGIQVTPDEDDHLLSPTKGICPKQENIAGPCRPAQLPAVAPIAASSHPHSSVITSPLRALGALPPCLPLPCCSARPVSGDGTQGEGQTEAPFGCQCQLSGKDEPSSYICTTCKQPFNSAWFLLQHAQNTHGFRIYLEPGPASSSLTPRLTIPPPLGPEAVAQSPLMNFLGDSNPFNLLRMTGPILRDHPGFGEGRLPGTPPLFSPPPRHHLDPHRLSAEEMGLVAQHPSAFDRVMRLNPMAIDSPAMDFSRRLRELAGNSSTPPPVSPGRGNPMHRLLNPFQPSPKSPFLSTPPLPPMPPGGTPPPQPPAKSKSCEFCGKTFKFQSNLIVHRRSHTGEKPYKCQLCDHACSQASKLKRHMKTHMHKAGSLAGRSDDGLSAASSPEPGTSELAGEGLKAADGDFRHHESDPSLGHEPEEEDEEEEEEEEELLLENESRPESSFSMDSELSRNRENGGGGVPGVPGAGGGAAKALADEKALVLGKVMENVGLGALPQYGELLADKQKRGAFLKRAAGGGDAGDDDDAGGCGDAGAGGAVNGRGGGFAPGTEPFPGLFPRKPAPLPSPGLNSAAKRIKVEKDLELPPAALIPSENVYSQWLVGYAASRHFMKDPFLGFTDARQSPFATSSEHSSENGSLRFSTPPGDLLDGGLSGRSGTASGGSTPHLGGPGPGRPSSKEGRRSDTCEYCGKVFKNCSNLTVHRRSHTGERPYKCELCNYACAQSSKLTRHMKTHGQIGKEVYRCDICQMPFSVYSTLEKHMKKWHGEHLLTNDVKIEQAERS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
2Phosphorylation------MSRRKQGNP
------CCCCCCCCH
40.5726074081
13PhosphorylationQGNPQHLSQRELITP
CCCHHHCCCCCCCCC
25.6826074081
19PhosphorylationLSQRELITPEADHVE
CCCCCCCCCCCCHHH
27.9226074081
79UbiquitinationVFIEHKRKQCGGSLG
EEEEECCHHCCCCCH
55.53-
79 (in isoform 2)Ubiquitination-55.53-
84PhosphorylationKRKQCGGSLGACYDK
CCHHCCCCCHHHHHH
14.6530576142
89PhosphorylationGGSLGACYDKALDKD
CCCCHHHHHHHHCCC
21.6826074081
91UbiquitinationSLGACYDKALDKDSP
CCHHHHHHHHCCCCC
25.11-
95UbiquitinationCYDKALDKDSPPPSS
HHHHHHCCCCCCCCC
62.04-
97PhosphorylationDKALDKDSPPPSSRS
HHHHCCCCCCCCCHH
45.0823401153
101PhosphorylationDKDSPPPSSRSELRK
CCCCCCCCCHHHHHH
44.1223403867
102PhosphorylationKDSPPPSSRSELRKV
CCCCCCCCHHHHHHC
45.6723403867
104PhosphorylationSPPPSSRSELRKVSE
CCCCCCHHHHHHCCC
42.8223403867
108UbiquitinationSSRSELRKVSEPVEI
CCHHHHHHCCCCEEE
63.84-
110PhosphorylationRSELRKVSEPVEIGI
HHHHHHCCCCEEEEE
38.9426074081
120PhosphorylationVEIGIQVTPDEDDHL
EEEEEEECCCCCCCC
14.5130266825
129PhosphorylationDEDDHLLSPTKGICP
CCCCCCCCCCCCCCC
36.5630266825
129 (in isoform 2)Phosphorylation-36.5625056879
131PhosphorylationDDHLLSPTKGICPKQ
CCCCCCCCCCCCCCC
38.2330266825
132UbiquitinationDHLLSPTKGICPKQE
CCCCCCCCCCCCCCC
50.06-
137SumoylationPTKGICPKQENIAGP
CCCCCCCCCCCCCCC
66.8728112733
137UbiquitinationPTKGICPKQENIAGP
CCCCCCCCCCCCCCC
66.87-
137 (in isoform 2)Ubiquitination-66.87-
144UbiquitinationKQENIAGPCRPAQLP
CCCCCCCCCCHHHCC
11.26-
144 (in isoform 2)Ubiquitination-11.26-
156 (in isoform 2)Ubiquitination-3.45-
159PhosphorylationAVAPIAASSHPHSSV
CCCCCCCCCCCCCHH
21.8430576142
160PhosphorylationVAPIAASSHPHSSVI
CCCCCCCCCCCCHHH
35.9930576142
164PhosphorylationAASSHPHSSVITSPL
CCCCCCCCHHHCHHH
30.6530576142
165PhosphorylationASSHPHSSVITSPLR
CCCCCCCHHHCHHHH
17.9530576142
168PhosphorylationHPHSSVITSPLRALG
CCCCHHHCHHHHHCC
23.3330576142
169PhosphorylationPHSSVITSPLRALGA
CCCHHHCHHHHHCCC
15.7128464451
192PhosphorylationCCSARPVSGDGTQGE
EEECCEECCCCCCCC
33.5728111955
196PhosphorylationRPVSGDGTQGEGQTE
CEECCCCCCCCCCCC
37.8328111955
215UbiquitinationCQCQLSGKDEPSSYI
CEEEECCCCCCCCEE
56.39-
249PhosphorylationNTHGFRIYLEPGPAS
HCCCEEEEEECCCCC
10.7626552605
256PhosphorylationYLEPGPASSSLTPRL
EEECCCCCCCCCCCE
24.4821082442
257PhosphorylationLEPGPASSSLTPRLT
EECCCCCCCCCCCEE
31.3229978859
258PhosphorylationEPGPASSSLTPRLTI
ECCCCCCCCCCCEEC
33.4928348404
260PhosphorylationGPASSSLTPRLTIPP
CCCCCCCCCCEECCC
14.3321082442
262MethylationASSSLTPRLTIPPPL
CCCCCCCCEECCCCC
38.95-
264PhosphorylationSSLTPRLTIPPPLGP
CCCCCCEECCCCCCH
32.4928464451
277PhosphorylationGPEAVAQSPLMNFLG
CHHHHHCCCCHHHHC
15.4028464451
286PhosphorylationLMNFLGDSNPFNLLR
CHHHHCCCCHHHHHH
44.60-
293MethylationSNPFNLLRMTGPILR
CCHHHHHHCCCCCCC
24.63-
300MethylationRMTGPILRDHPGFGE
HCCCCCCCCCCCCCC
40.69-
313PhosphorylationGEGRLPGTPPLFSPP
CCCCCCCCCCCCCCC
21.5723898821
318PhosphorylationPGTPPLFSPPPRHHL
CCCCCCCCCCCCCCC
44.1526329039
322Asymmetric dimethylargininePLFSPPPRHHLDPHR
CCCCCCCCCCCCHHH
35.31-
322MethylationPLFSPPPRHHLDPHR
CCCCCCCCCCCCHHH
35.31-
331PhosphorylationHLDPHRLSAEEMGLV
CCCHHHCCHHHHCHH
33.3224850871
343PhosphorylationGLVAQHPSAFDRVMR
CHHHCCCHHHHHHHH
39.1724850871
354SulfoxidationRVMRLNPMAIDSPAM
HHHHHCCCCCCCCCH
5.0621406390
356 (in isoform 2)Ubiquitination-4.36-
358PhosphorylationLNPMAIDSPAMDFSR
HCCCCCCCCCHHHHH
14.4030576142
363 (in isoform 2)Ubiquitination-3.82-
364PhosphorylationDSPAMDFSRRLRELA
CCCCHHHHHHHHHHH
16.5430576142
366 (in isoform 2)Ubiquitination-36.58-
374PhosphorylationLRELAGNSSTPPPVS
HHHHHCCCCCCCCCC
34.3723401153
375PhosphorylationRELAGNSSTPPPVSP
HHHHCCCCCCCCCCC
49.2730266825
376PhosphorylationELAGNSSTPPPVSPG
HHHCCCCCCCCCCCC
39.3723401153
381PhosphorylationSSTPPPVSPGRGNPM
CCCCCCCCCCCCCHH
27.6623401153
385 (in isoform 2)Ubiquitination-48.81-
398PhosphorylationLLNPFQPSPKSPFLS
HCCCCCCCCCCCCCC
33.8930266825
398 (in isoform 2)Ubiquitination-33.89-
400 (in isoform 2)Ubiquitination-75.09-
401PhosphorylationPFQPSPKSPFLSTPP
CCCCCCCCCCCCCCC
25.0330576142
405PhosphorylationSPKSPFLSTPPLPPM
CCCCCCCCCCCCCCC
38.9726074081
406PhosphorylationPKSPFLSTPPLPPMP
CCCCCCCCCCCCCCC
30.9528122231
417PhosphorylationPPMPPGGTPPPQPPA
CCCCCCCCCCCCCCC
38.2428348404
426PhosphorylationPPQPPAKSKSCEFCG
CCCCCCCCCCCCCCC
31.7226074081
427UbiquitinationPQPPAKSKSCEFCGK
CCCCCCCCCCCCCCC
59.42-
428PhosphorylationQPPAKSKSCEFCGKT
CCCCCCCCCCCCCCE
26.4326074081
434AcetylationKSCEFCGKTFKFQSN
CCCCCCCCEEEEECC
52.5523749302
434UbiquitinationKSCEFCGKTFKFQSN
CCCCCCCCEEEEECC
52.55-
450PhosphorylationIVHRRSHTGEKPYKC
EEECCCCCCCCCCCC
48.5624719451
456UbiquitinationHTGEKPYKCQLCDHA
CCCCCCCCCCCCHHH
24.83-
465PhosphorylationQLCDHACSQASKLKR
CCCHHHHHHHHHHHH
29.5730576142
468PhosphorylationDHACSQASKLKRHMK
HHHHHHHHHHHHHHH
30.7730576142
469AcetylationHACSQASKLKRHMKT
HHHHHHHHHHHHHHH
62.1325953088
469UbiquitinationHACSQASKLKRHMKT
HHHHHHHHHHHHHHH
62.13-
480UbiquitinationHMKTHMHKAGSLAGR
HHHHHHHHHHCCCCC
47.03-
483PhosphorylationTHMHKAGSLAGRSDD
HHHHHHHCCCCCCCC
21.6530576142
488PhosphorylationAGSLAGRSDDGLSAA
HHCCCCCCCCCCCCC
38.8530177828
493PhosphorylationGRSDDGLSAASSPEP
CCCCCCCCCCCCCCC
27.5828348404
496PhosphorylationDDGLSAASSPEPGTS
CCCCCCCCCCCCCCC
46.2523401153
497PhosphorylationDGLSAASSPEPGTSE
CCCCCCCCCCCCCCH
28.6722617229
502PhosphorylationASSPEPGTSELAGEG
CCCCCCCCCHHCCCC
29.7328122231
503PhosphorylationSSPEPGTSELAGEGL
CCCCCCCCHHCCCCC
36.2130576142
514 (in isoform 2)Ubiquitination-63.15-
520 (in isoform 2)Ubiquitination-31.81-
522PhosphorylationGDFRHHESDPSLGHE
CCCCCCCCCCCCCCC
50.9226074081
525PhosphorylationRHHESDPSLGHEPEE
CCCCCCCCCCCCCCC
52.5626074081
546 (in isoform 2)Ubiquitination-11.82-
548 (in isoform 2)Ubiquitination-53.14-
550PhosphorylationELLLENESRPESSFS
HHHHCCCCCCCCCCC
65.79-
554 (in isoform 2)Ubiquitination-39.09-
557PhosphorylationSRPESSFSMDSELSR
CCCCCCCCCCHHHHH
24.51-
560PhosphorylationESSFSMDSELSRNRE
CCCCCCCHHHHHCCC
31.62-
585UbiquitinationGAGGGAAKALADEKA
CCCCHHHHHHHHHHH
43.32-
591AcetylationAKALADEKALVLGKV
HHHHHHHHHHHHHHH
47.7925953088
591SumoylationAKALADEKALVLGKV
HHHHHHHHHHHHHHH
47.7928112733
591UbiquitinationAKALADEKALVLGKV
HHHHHHHHHHHHHHH
47.79-
597UbiquitinationEKALVLGKVMENVGL
HHHHHHHHHHHHCCC
33.96-
601 (in isoform 2)Ubiquitination-18.30-
610PhosphorylationGLGALPQYGELLADK
CCCCCCHHHHHHHHH
15.6128796482
615 (in isoform 2)Ubiquitination-34.28-
617AcetylationYGELLADKQKRGAFL
HHHHHHHHHHHHHHH
52.7025953088
617SumoylationYGELLADKQKRGAFL
HHHHHHHHHHHHHHH
52.7028112733
617UbiquitinationYGELLADKQKRGAFL
HHHHHHHHHHHHHHH
52.70-
619UbiquitinationELLADKQKRGAFLKR
HHHHHHHHHHHHHHH
59.55-
625UbiquitinationQKRGAFLKRAAGGGD
HHHHHHHHHHCCCCC
33.27-
652 (in isoform 2)Ubiquitination-33.63-
662PhosphorylationGGGFAPGTEPFPGLF
CCCCCCCCCCCCCCC
39.15-
671MethylationPFPGLFPRKPAPLPS
CCCCCCCCCCCCCCC
50.70-
672UbiquitinationFPGLFPRKPAPLPSP
CCCCCCCCCCCCCCC
45.85-
678PhosphorylationRKPAPLPSPGLNSAA
CCCCCCCCCCCCHHH
39.0030266825
683PhosphorylationLPSPGLNSAAKRIKV
CCCCCCCHHHHHCCC
34.3530576142
686AcetylationPGLNSAAKRIKVEKD
CCCCHHHHHCCCCCC
55.1425953088
686SumoylationPGLNSAAKRIKVEKD
CCCCHHHHHCCCCCC
55.1428112733
686UbiquitinationPGLNSAAKRIKVEKD
CCCCHHHHHCCCCCC
55.14-
689UbiquitinationNSAAKRIKVEKDLEL
CHHHHHCCCCCCCCC
48.66-
719 (in isoform 2)Ubiquitination-23.49-
723SumoylationAASRHFMKDPFLGFT
HHHHHHHCCCCCCCC
62.4028112733
723UbiquitinationAASRHFMKDPFLGFT
HHHHHHHCCCCCCCC
62.40-
730PhosphorylationKDPFLGFTDARQSPF
CCCCCCCCCCCCCCC
27.2726074081
732 (in isoform 2)Ubiquitination-14.35-
735PhosphorylationGFTDARQSPFATSSE
CCCCCCCCCCCCCCC
19.2130576142
735 (in isoform 2)Ubiquitination-19.21-
739PhosphorylationARQSPFATSSEHSSE
CCCCCCCCCCCCCCC
32.9126074081
740PhosphorylationRQSPFATSSEHSSEN
CCCCCCCCCCCCCCC
30.2426074081
741PhosphorylationQSPFATSSEHSSENG
CCCCCCCCCCCCCCC
34.6726074081
744PhosphorylationFATSSEHSSENGSLR
CCCCCCCCCCCCCEE
34.9826074081
745PhosphorylationATSSEHSSENGSLRF
CCCCCCCCCCCCEEE
36.6726074081
749PhosphorylationEHSSENGSLRFSTPP
CCCCCCCCEEECCCC
28.1426074081
751MethylationSSENGSLRFSTPPGD
CCCCCCEEECCCCCC
25.76-
753PhosphorylationENGSLRFSTPPGDLL
CCCCEEECCCCCCCC
33.3023401153
754PhosphorylationNGSLRFSTPPGDLLD
CCCEEECCCCCCCCC
30.6930266825
754 (in isoform 2)Ubiquitination-30.69-
765PhosphorylationDLLDGGLSGRSGTAS
CCCCCCCCCCCCCCC
35.1226074081
767 (in isoform 2)Ubiquitination-28.65-
768PhosphorylationDGGLSGRSGTASGGS
CCCCCCCCCCCCCCC
43.9828348404
770PhosphorylationGLSGRSGTASGGSTP
CCCCCCCCCCCCCCC
20.9228348404
772PhosphorylationSGRSGTASGGSTPHL
CCCCCCCCCCCCCCC
43.4523401153
775PhosphorylationSGTASGGSTPHLGGP
CCCCCCCCCCCCCCC
42.1423401153
776PhosphorylationGTASGGSTPHLGGPG
CCCCCCCCCCCCCCC
20.2928348404
780 (in isoform 2)Ubiquitination-36.90-
788PhosphorylationGPGPGRPSSKEGRRS
CCCCCCCCCCCCCCC
53.3223401153
789PhosphorylationPGPGRPSSKEGRRSD
CCCCCCCCCCCCCCC
37.0930576142
790UbiquitinationGPGRPSSKEGRRSDT
CCCCCCCCCCCCCCC
69.40-
795PhosphorylationSSKEGRRSDTCEYCG
CCCCCCCCCCCHHHH
35.5930576142
797PhosphorylationKEGRRSDTCEYCGKV
CCCCCCCCCHHHHHH
14.4228111955
800 (in isoform 2)Ubiquitination-14.51-
803AcetylationDTCEYCGKVFKNCSN
CCCHHHHHHHHHCCC
40.7225953088
803UbiquitinationDTCEYCGKVFKNCSN
CCCHHHHHHHHHCCC
40.72-
803 (in isoform 2)Ubiquitination-40.72-
804 (in isoform 2)Ubiquitination-5.11-
806UbiquitinationEYCGKVFKNCSNLTV
HHHHHHHHHCCCCEE
61.09-
809PhosphorylationGKVFKNCSNLTVHRR
HHHHHHCCCCEEECC
44.24-
816 (in isoform 2)Ubiquitination-20.22-
817PhosphorylationNLTVHRRSHTGERPY
CCEEECCCCCCCCCE
25.9224719451
819PhosphorylationTVHRRSHTGERPYKC
EEECCCCCCCCCEEC
41.8228464451
825UbiquitinationHTGERPYKCELCNYA
CCCCCCEECEECCHH
24.74-
838AcetylationYACAQSSKLTRHMKT
HHHHCCHHHHHHHHH
60.1625953088
838UbiquitinationYACAQSSKLTRHMKT
HHHHCCHHHHHHHHH
60.16-
840PhosphorylationCAQSSKLTRHMKTHG
HHCCHHHHHHHHHHC
23.4330576142
844UbiquitinationSKLTRHMKTHGQIGK
HHHHHHHHHHCCCCC
31.11-
851AcetylationKTHGQIGKEVYRCDI
HHHCCCCCEEEECCC
45.7119608861
851UbiquitinationKTHGQIGKEVYRCDI
HHHCCCCCEEEECCC
45.7119608861
854PhosphorylationGQIGKEVYRCDICQM
CCCCCEEEECCCCCC
13.4530576142
864PhosphorylationDICQMPFSVYSTLEK
CCCCCCCCHHHHHHH
17.8021406692
866PhosphorylationCQMPFSVYSTLEKHM
CCCCCCHHHHHHHHH
8.5021406692
867PhosphorylationQMPFSVYSTLEKHMK
CCCCCHHHHHHHHHH
25.1021406692
868PhosphorylationMPFSVYSTLEKHMKK
CCCCHHHHHHHHHHH
22.6521406692
871UbiquitinationSVYSTLEKHMKKWHG
CHHHHHHHHHHHHCC
52.70-
875UbiquitinationTLEKHMKKWHGEHLL
HHHHHHHHHCCHHHC
36.53-
887SumoylationHLLTNDVKIEQAERS
HHCCCCCCHHHHHCC
43.3128112733
887UbiquitinationHLLTNDVKIEQAERS
HHCCCCCCHHHHHCC
43.31-
894PhosphorylationKIEQAERS-------
CHHHHHCC-------
35.7624719451

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
2SPhosphorylationKinasePRKCAP17252
GPS

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of BC11B_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of BC11B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CHD4_HUMANCHD4physical
16091750
MTA2_HUMANMTA2physical
16091750
MTA1_HUMANMTA1physical
16091750
RBBP7_HUMANRBBP7physical
16091750
RBBP4_HUMANRBBP4physical
16091750
HDAC2_HUMANHDAC2physical
16091750
HDAC1_HUMANHDAC1physical
16091750
MBD3_HUMANMBD3physical
16091750
COT1_HUMANNR2F1physical
15849318
SP1_HUMANSP1physical
15849318
HDAC1_HUMANHDAC1physical
17245431
HDAC2_HUMANHDAC2physical
17245431
HDAC3_HUMANHDAC3physical
17245431

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of BC11B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-851, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-97; THR-120; SER-256;THR-260; SER-277; THR-313; SER-318; SER-358; THR-376; SER-381;THR-417; SER-483; SER-488; SER-493; SER-496; SER-497; SER-678; THR-754AND SER-765, AND MASS SPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-772, AND MASSSPECTROMETRY.

TOP